Recombinant multi-species SEC23A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SEC23A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the SEC23 subfamily of the SEC23/SEC24 family. It is part of a protein complex and found in the ribosome-free transitional face of the endoplasmic reticulum (ER) and associated vesicles. This protein has similarity to yeast Sec23p component of COPII. COPII is the coat protein complex responsible for vesicle budding from the ER. The encoded protein is suggested to play a role in the ER-Golgi protein trafficking. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CLSD,Msec23,Protein transport protein Sec23A,SEC23-related protein A,SEC23A,Sec23a,Sec23r,hSec23A

Target products collectionGo to SEC23A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3542-Ag-1/ GM-Tg-hg-IP3542-Ag-2 Human SEC23A protein Human
GM-Tg-rg-IP3542-Ag-1/ GM-Tg-rg-IP3542-Ag-2 Rat SEC23A protein Rat
GM-Tg-mg-IP3542-Ag-1/ GM-Tg-mg-IP3542-Ag-2 Mouse SEC23A protein Mouse
GM-Tg-cynog-IP3542-Ag-1/ GM-Tg-cynog-IP3542-Ag-2 Cynomolgus/Rhesus macaque SEC23A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3542-Ag-1/ GM-Tg-felg-IP3542-Ag-2 Feline SEC23A protein Feline
GM-Tg-cang-IP3542-Ag-1/ GM-Tg-cang-IP3542-Ag-2 Canine SEC23A protein Canine
GM-Tg-bovg-IP3542-Ag-1/ GM-Tg-bovg-IP3542-Ag-2 Bovine SEC23A protein Bovine
GM-Tg-equg-IP3542-Ag-1/ GM-Tg-equg-IP3542-Ag-2 Equine SEC23A protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3542-Ag-1/ GM-Tg-hg-IP3542-Ag-2; GM-Tg-rg-IP3542-Ag-1/ GM-Tg-rg-IP3542-Ag-2;
GM-Tg-mg-IP3542-Ag-1/ GM-Tg-mg-IP3542-Ag-2; GM-Tg-cynog-IP3542-Ag-1/ GM-Tg-cynog-IP3542-Ag-2;
GM-Tg-felg-IP3542-Ag-1/ GM-Tg-felg-IP3542-Ag-2; GM-Tg-cang-IP3542-Ag-1/ GM-Tg-cang-IP3542-Ag-2;
GM-Tg-bovg-IP3542-Ag-1/ GM-Tg-bovg-IP3542-Ag-2; GM-Tg-equg-IP3542-Ag-1/ GM-Tg-equg-IP3542-Ag-2
Products Name SEC23A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SEC23A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SEC23A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.